Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB120 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11
22
33
44 Req. No. 575 Page 1 1
55 2
66 3
77 4
88 5
99 6
1010 7
1111 8
1212 9
1313 10
1414 11
1515 12
1616 13
1717 14
1818 15
1919 16
2020 17
2121 18
2222 19
2323 20
2424 21
2525 22
2626 23
2727 24
2828 1
2929 2
3030 3
3131 4
3232 5
3333 6
3434 7
3535 8
3636 9
3737 10
3838 11
3939 12
4040 13
4141 14
4242 15
4343 16
4444 17
4545 18
4646 19
4747 20
4848 21
4949 22
5050 23
5151 24
5252
5353 STATE OF OKLAHOMA
5454
5555 1st Session of the 58th Legislature (2021)
5656
5757 SENATE BILL 120 By: Standridge
5858
5959
6060
6161
6262
6363 AS INTRODUCED
6464
6565 An Act relating to prescription drugs; cr eating the
6666 Prescription Drug Safety and Cost Reduction Pilot
6767 Program Act; providing short ti tle; directing the
6868 Oklahoma Health Care Authority to submit certain
6969 application to the United States Secretary of Health
7070 and Human Services; requiring the Authority to
7171 identify and make available certain drugs to
7272 participating pharmacies ; stipulating criteria for
7373 drugs; requiring the Authority to purchase drugs from
7474 certain suppliers; requiring issuance of unique
7575 identification number to certain drugs for specified
7676 purposes; limiting importation pilot progr am to
7777 certain pharmacies; directing creation of certain
7878 application and license verification process;
7979 establishing certain fee; requiring the Authority to
8080 contract with certain entity for administration of
8181 the importation pilot program; prohibiting use of
8282 certain entity; providing certain claims and
8383 reimbursement process; setting reimbursement amounts;
8484 prohibiting certain reimbursement; providing certain
8585 appeals process for aggrieved pharmacy; providing for
8686 certain adjustment and interest; prohibiting certa in
8787 fees; prohibiting certain actions by pharmaceuti cal
8888 manufacturer, supplier or other entity; imposing
8989 certain duties on the Authority; directing the
9090 Authority to form certain advisory council upon
9191 approval of pilot program; stating purpose of
9292 advisory council; directing promulgation of rules;
9393 providing for codification; providing an effective
9494 date; and declaring an emergency .
9595
9696
9797
9898
9999 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
100100
101101
102102 Req. No. 575 Page 2 1
103103 2
104104 3
105105 4
106106 5
107107 6
108108 7
109109 8
110110 9
111111 10
112112 11
113113 12
114114 13
115115 14
116116 15
117117 16
118118 17
119119 18
120120 19
121121 20
122122 21
123123 22
124124 23
125125 24
126126 1
127127 2
128128 3
129129 4
130130 5
131131 6
132132 7
133133 8
134134 9
135135 10
136136 11
137137 12
138138 13
139139 14
140140 15
141141 16
142142 17
143143 18
144144 19
145145 20
146146 21
147147 22
148148 23
149149 24
150150
151151 SECTION 1. NEW LAW A new section of law to be codified
152152 in the Oklahoma Statutes as Section 3092 of Title 63, unless there
153153 is created a duplication in numbering, reads as follows:
154154 A. This section shall be known and may be cited as the
155155 “Prescription Drug Safety and Cost Reduction Importation Pilot
156156 Program Act”.
157157 B. The Oklahoma Health Care Authority shall submit an
158158 application to the United States Secretary of Health and Human
159159 Services for the purpose of establishing a prescription drug
160160 importation pilot program for the state Medicaid program to import
161161 pharmaceutical drugs from one or more countries approved by the
162162 United States Food and Drug Administration (FDA). The importation
163163 pilot program shall comply with the applicable requirements of 21
164164 U.S.C., Section 384 including, but not limited to, the requirements
165165 pertaining to safety and cost savings .
166166 C. The Authority shall identify the top twenty (20) most
167167 frequently prescribed drugs through the state Medicaid program that
168168 have a large cost differential between Canadian and United States
169169 average prices whose importation will create significant cost
170170 savings in the state Medicaid program . Not less than six (6) months
171171 following approval of the application described in subsection B of
172172 this section, the Authority shall make available the top twenty (20)
173173 highly prescribed drugs as provided in this paragraph to pharmacies
174174 willing to participate. Prescription drugs identified:
175175
176176
177177 Req. No. 575 Page 3 1
178178 2
179179 3
180180 4
181181 5
182182 6
183183 7
184184 8
185185 9
186186 10
187187 11
188188 12
189189 13
190190 14
191191 15
192192 16
193193 17
194194 18
195195 19
196196 20
197197 21
198198 22
199199 23
200200 24
201201 1
202202 2
203203 3
204204 4
205205 5
206206 6
207207 7
208208 8
209209 9
210210 10
211211 11
212212 12
213213 13
214214 14
215215 15
216216 16
217217 17
218218 18
219219 19
220220 20
221221 21
222222 22
223223 23
224224 24
225225
226226 1. Shall be legally importable under applicable federal and
227227 state law;
228228 2. Shall not include a controlled dangerous substance;
229229 3. Shall not include a biological product ;
230230 4. Shall not include an infused drug, including a peritoneal
231231 dialysis solution;
232232 5. Shall not include marijuana, medical ma rijuana, cannabidiol
233233 or related derivatives;
234234 6. Shall not include an intravenously injected drug; and
235235 7. Shall be in compliance with applicab le state and federal
236236 standards for safety and effectiveness.
237237 D. The Authority shall purchase drugs o nly from suppliers
238238 approved by FDA in countries approved by FDA. Except for drugs to
239239 which FDA issues a National Drug Code number, the Authority shall
240240 issue a unique identification numbe r to each drug in the importation
241241 pilot program for the purposes of tracking and submitting cl aims to
242242 the Authority.
243243 E. Only a retail pharmacy located in this state that has a
244244 valid license issued by the State Board of Phar macy may participate
245245 in the importation pilot program. The Authority shall create a
246246 simple application for applying pharmacie s which shall include a
247247 field for the pharmacy’s license number. The application shall be
248248 made available on the website of the Au thority. Upon receipt of a
249249 completed application, the Authority shall verify the license with
250250
251251
252252 Req. No. 575 Page 4 1
253253 2
254254 3
255255 4
256256 5
257257 6
258258 7
259259 8
260260 9
261261 10
262262 11
263263 12
264264 13
265265 14
266266 15
267267 16
268268 17
269269 18
270270 19
271271 20
272272 21
273273 22
274274 23
275275 24
276276 1
277277 2
278278 3
279279 4
280280 5
281281 6
282282 7
283283 8
284284 9
285285 10
286286 11
287287 12
288288 13
289289 14
290290 15
291291 16
292292 17
293293 18
294294 19
295295 20
296296 21
297297 22
298298 23
299299 24
300300
301301 the Board and issue a permit to the pharmacy within thirty (30)
302302 calendar days authorizing the pharmacy to purchase drugs through the
303303 importation pilot program.
304304 F. The Authority shall establish a nominal fee -per-unit of
305305 imported pharmaceutical drug s, not to exceed three percent (3%) of
306306 the cost of the unit, to cover the costs of administration,
307307 warehousing and distribution in addition to t he absolute cost of
308308 importation.
309309 G. The Authority shall c ontract with the entity currently
310310 tasked with administering pharmacy b enefits for the state Medicaid
311311 program on the effective date of this act for the purpose of
312312 administering the importation pilot program. A pharmacy benefit
313313 manager shall not be used for the importation pilot program.
314314 H. 1. A pharmacy participating in the importation pilot
315315 program shall submit claims to the Authority or the Authority’s
316316 contracted third-party administrator, and shall be reimbursed
317317 through the state Medicaid program as provided in this subsection.
318318 2. The pharmacy shall be reimbursed in an amount equal to:
319319 a. for a brand-name drug, the cost to the pharmacy of the
320320 drug, plus fifteen percent (15%), plus Fifteen Dollars
321321 ($15.00), or
322322 b. for a generic drug, the cost to the pharmacy of the
323323 drug, plus thirty percent (30%), plus Fifteen Dollars
324324 ($15.00).
325325
326326
327327 Req. No. 575 Page 5 1
328328 2
329329 3
330330 4
331331 5
332332 6
333333 7
334334 8
335335 9
336336 10
337337 11
338338 12
339339 13
340340 14
341341 15
342342 16
343343 17
344344 18
345345 19
346346 20
347347 21
348348 22
349349 23
350350 24
351351 1
352352 2
353353 3
354354 4
355355 5
356356 6
357357 7
358358 8
359359 9
360360 10
361361 11
362362 12
363363 13
364364 14
365365 15
366366 16
367367 17
368368 18
369369 19
370370 20
371371 21
372372 22
373373 23
374374 24
375375
376376 3. No pharmacy shall be reimbursed in an amount more or less
377377 than as provided in this subsection. If a pharmacy is reimbursed
378378 less than as provided in this subsection, the pharmacy shall , upon
379379 proof of purchase, be reimbursed the differe nce of the amount
380380 provided in this subsection and the amount of the actual
381381 reimbursement within thirty (30) days of an appeal and subsequent
382382 decision by the Authority in favor of the pharmacy . Any adjustments
383383 not reimbursed to the pharmacy within thirty ( 30) days of the
384384 favorable decision shall be assessed interest with an annual
385385 percentage rate of twenty-five percent (25%) of the owed adjustment
386386 compounded daily until the payment is sent to the pharmacy. The
387387 accrued interest shall be paid to the pharmacy. Except as provided
388388 in this section, no fees or other charges shall be assessed to a
389389 pharmacy in relation to the importation pilot program or any
390390 purchases executed pursuant to the importation pilot program.
391391 I. 1. A pharmaceutical manufacturer, supplier or any other
392392 entity shall not:
393393 a. give or receive kickbacks or rebates, or participate
394394 in any other scheme that interferes with the
395395 transparency of the importation pilot program or
396396 interferes with pharmacies obtaining the lowest
397397 possible prices on drugs purchased through the
398398 importation pilot program,
399399
400400
401401 Req. No. 575 Page 6 1
402402 2
403403 3
404404 4
405405 5
406406 6
407407 7
408408 8
409409 9
410410 10
411411 11
412412 12
413413 13
414414 14
415415 15
416416 16
417417 17
418418 18
419419 19
420420 20
421421 21
422422 22
423423 23
424424 24
425425 1
426426 2
427427 3
428428 4
429429 5
430430 6
431431 7
432432 8
433433 9
434434 10
435435 11
436436 12
437437 13
438438 14
439439 15
440440 16
441441 17
442442 18
443443 19
444444 20
445445 21
446446 22
447447 23
448448 24
449449
450450 b. take any action, by agreement, unilaterally or
451451 otherwise, that has the effect of fixing or otherwise
452452 controlling the price that a pharmaceutical sup plier,
453453 distributor or dispenser charges or advertises from
454454 pharmaceuticals in the importation pilot program,
455455 c. discriminate against a pharmaceutical supplier,
456456 distributor or dispenser based on whether the
457457 supplier, distributor or dispenser participates in the
458458 importation pilot program, or
459459 d. manipulate the pharmaceutical market in this state or
460460 adversely affect consumer access to pharmaceuticals
461461 under the importation pilot program;
462462 2. The Authority shall:
463463 a. ensure that savings are passed to consumers and not
464464 recouped or clawed back, retroa ctively or otherwise,
465465 by pharmaceutical manufacturers or any other entity,
466466 b. ensure that the importation pilot program complies
467467 with the requirements of 21 U.S.C, Section 360eee and
468468 360eee-1, pertaining to the track and trace
469469 requirements in Title II of the Drug Security and
470470 Quality Act before imported prescription drugs come
471471 into possession of the wholesaler, and
472472 c. establish a process for seeking all appropriate
473473 federal approvals, waivers, exemptions or agreements,
474474
475475
476476 Req. No. 575 Page 7 1
477477 2
478478 3
479479 4
480480 5
481481 6
482482 7
483483 8
484484 9
485485 10
486486 11
487487 12
488488 13
489489 14
490490 15
491491 16
492492 17
493493 18
494494 19
495495 20
496496 21
497497 22
498498 23
499499 24
500500 1
501501 2
502502 3
503503 4
504504 5
505505 6
506506 7
507507 8
508508 9
509509 10
510510 11
511511 12
512512 13
513513 14
514514 15
515515 16
516516 17
517517 18
518518 19
519519 20
520520 21
521521 22
522522 23
523523 24
524524
525525 or a combination thereof, as needed to enable all
526526 covered entities enrolled in or e ligible for the
527527 federal 340B Drug Pricing Prog ram to participate in
528528 the importation pilot program to the fullest extent
529529 possible without jeo pardizing eligibility in the 340B
530530 Program.
531531 J. Upon approval of the application described in subsection A
532532 of this section, the Authority shall form an advisory council that
533533 consists of key stakeholders including, but not limited to, consumer
534534 and patient advocates, pharmacists, contracted providers under the
535535 state Medicaid program and governmental agencies necessary to
536536 propose rules and changes in law to enable the Authority to
537537 implement the provisions of this section.
538538 K. Upon approval of the application de scribed in subsection A
539539 of this section, the Oklahoma Health Care Authority Board shall
540540 promulgate rules to implement the provis ions of this section.
541541 SECTION 2. This act shall become effective July 1, 2021.
542542 SECTION 3. It being immediately necessary for the preservation
543543 of the public peace, health or safety, an emergency is hereby
544544 declared to exist, by reason whereof this act shall take effect and
545545 be in full force from and after its passage and approval.
546546
547547 58-1-575 DC 12/9/2020 4:44:36 PM